[HTML][HTML] The Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients With Atrial Fibrillation: A Network Meta-Analysis
QM Salah, S Bhandari, A Chand, S Khan, SHA Tirmzi… - Cureus, 2023 - ncbi.nlm.nih.gov
Atrial fibrillation (AF) is a cardiac condition characterized by an irregular heart rhythm, which
is increasingly prevalent in the modern era. All international guidelines strongly advise the …
is increasingly prevalent in the modern era. All international guidelines strongly advise the …
A real-world exploration into clinical outcomes of direct oral anticoagulant dosing regimens in morbidly obese patients using data-driven approaches
EM Nwanosike, W Sunter, MA Ansari… - American Journal of …, 2023 - Springer
Introduction The clinical outcomes of direct oral anticoagulant (DOAC) dosage regimens in
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …
morbid obesity are uncertain due to limited clinical evidence. This study seeks to bridge this …
Emulating a target trial to assess effect modification: an application to obesity in the comparative effectiveness and safety of apixaban versus warfarin in non-valvular …
TM Bin Hammad, E Powell, PJ Baptiste, I Douglas… - medRxiv, 2023 - medrxiv.org
Anticoagulation therapy is recommended for patients with non-valvular atrial fibrillation
(NVAF) and an increased risk of stroke. Although apixaban showed superiority over warfarin …
(NVAF) and an increased risk of stroke. Although apixaban showed superiority over warfarin …
Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme Obesity
BL Erstad, JF Barletta - Annals of Pharmacotherapy, 2023 - journals.sagepub.com
Objective: The objective of the study was to discuss the controversies surrounding the use
and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the …
and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the …
[PDF][PDF] DIRECT ORAL ANTICOAGULANTS (DOACs) USE IN PATIENTS WITH RENAL INSUFFICIENCY AND OBESITY
EM Nwanosike - 2023 - pure.hud.ac.uk
Abstract The popularity of Direct Oral AntiCoagulants (DOACs) for approved indications has
risen dramatically following their introduction to the UK's National Health Service (NHS) due …
risen dramatically following their introduction to the UK's National Health Service (NHS) due …
L'année cardiologique 2022: quelques points d'attention
JJ MONSUEZ - Medical Focus Journal, 2023 - journals.univ-tlemcen.dz
As every year, our discipline has progressed in each of its areas, most often with changes,
but sometimes also new orientations having an impact on daily practice. The selection …
but sometimes also new orientations having an impact on daily practice. The selection …